ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Amendment strips funding from two NIHM grants. NCI will commit $7 million to begin restructuring its clinical trials system, Institute director says.

July 1, 2005

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

EARLY Breast Cancer Screening Bill Gains Traction Among Jewish Groups

June 19, 2009

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003